| PERIOD ENDING | 31-Mar-09 | 30-Apr-08 | | Total Revenue | 2,926,460 | 1,491,233 | | Cost of Revenue | 2,621,861 | 1,345,592 | | | Gross Profit | 304,599 | 145,641 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 353,404 | 283,750 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (48,805) | (138,109) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (230,662) | 278,748 | | Earnings Before Interest And Taxes | (279,467) | 140,639 | | Interest Expense | 142,434 | 165,651 | | Income Before Tax | (421,901) | (25,012) | | Income Tax Expense | (144,690) | (19,810) | | Minority Interest | 82,995 | 22,004 | | | | Net Income From Continuing Ops | (188,088) | 16,563 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (188,088) | 16,563 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($188,088) | $16,563 |
|